AbCellera Biologics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 2836 www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

AbCellera Biologics Pivots to Pipeline as ABCL635 Phase II Hot Flash Data Nears, Exec Says - Mar 4th, 2026 9:50 am
Why AbCellera (ABCL) Is Up 11.5% After Narrowing Losses And Expanding ESOP Share Capacity – And What's Next - Feb 26th, 2026 7:09 pm
AbCellera Biologics (ABCL) Pivots to Clinical Stage as 2025 Revenue Hits $75M - Feb 26th, 2026 12:28 pm
AbCellera Biologics Inc. Q4 2025 Earnings Call Summary - Feb 25th, 2026 6:02 pm
AbCellera Biologics Inc (ABCL) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges - Feb 24th, 2026 10:00 pm
AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates - Feb 24th, 2026 7:55 pm
AbCellera Biologics Q4 Earnings Call Highlights - Feb 24th, 2026 4:26 pm
AbCellera Reports Full Year 2025 Business Results - Feb 24th, 2026 2:05 pm
3 New Stocks SoftBank Is Betting Big on in 2026 - Feb 19th, 2026 5:30 am
SoftBank Adds TwentyOne Capital, Exits Nvidia in Q4 Portfolio Shift - Feb 18th, 2026 7:43 am
Forget AI Stocks: This Pharma Giant Is Using AI to Dominate Drug Discovery - Feb 15th, 2026 4:00 pm
3 Promising Penny Stocks With At Least $600M Market Cap - Feb 12th, 2026 5:04 am
AbCellera to Present at Upcoming Investor Conferences in March and April 2026 - Feb 11th, 2026 2:05 pm
AbCellera Biologics Inc. (ABCL): A Bull Case Theory - Feb 2nd, 2026 5:49 pm
AbCellera’s ABCL635 Phase 2 Start Highlights Menopause Focus And Valuation Gap - Jan 30th, 2026 10:09 pm
AbCellera Biologics (ABCL) Valuation Check After Mixed Long Term Shareholder Returns - Jan 30th, 2026 6:13 am
Reassessing AbCellera Biologics (ABCL) After A Sharp 16.8% Weekly Share Price Drop - Jan 29th, 2026 11:17 pm
What Does Wall Street Think About AbCellera Biologics Inc. (ABCL)? - Jan 29th, 2026 11:49 am
AbCellera to Report Full Year 2025 Financial Results on February 24, 2026 - Jan 22nd, 2026 2:05 pm
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 - Jan 14th, 2026 6:07 pm